LLY
Eli Lilly and Company
Stock
$1,184.78+1.32 (+0.11%)Close Sep 28, 2026
LLY's revenue for 2025 was $65.18 billion, up 44.7% from the year before.
From SEC filings, Latest filing: 10-Q, Aug 5, 2026
| Revenue (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $79.67B | +49.6% | 21.6% | 12.6% |
| Revenue (TTM) | $79.67B |
|---|---|
| YoY | +49.6% |
| 5-year CAGR | 21.6% |
| 10-year CAGR | 12.6% |
Revenue
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $65.2B | +44.7% |
| 2024 | $45.0B | +32.0% |
| 2023 | $34.1B | +19.6% |
| 2022 | $28.5B | +0.8% |
| 2021 | $28.3B | +15.4% |
| 2020 | $24.5B | +9.9% |
| 2019 | $22.3B | +3.8% |
| 2018 | $21.5B | +7.6% |
| 2017 | $20.0B | −5.9% |
| 2016 | $21.2B | +6.3% |
| 2015 | $20.0B | +1.7% |
| 2014 | $19.6B | −15.1% |
| 2013 | $23.1B | +2.3% |
| 2012 | $22.6B | −6.9% |
| 2011 | $24.3B | +5.2% |
| 2010 | $23.1B | +5.7% |
| 2009 | $21.8B | +7.2% |
| 2008 | $20.4B | +9.3% |
| 2007 | $18.6B | — |